콘텐츠로 건너뛰기
주식/증권 📈 긍정적

Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street?

요약

The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.